首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1490048

經皮皮膚貼片市場：按類型、按應用、按分銷管道、按地區

Transdermal Skin Patches Market, By Type, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月17日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球經皮皮膚貼片市場規模估計為87.9億美元，預計到2031年將達到128.2億美元，2024年至2031年年複合成長率為5.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	87.9億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測2024-2031年年複合成長率：	5.50%	2031年價值預測	128.2億美元

圖：2024年依地區分類的經皮皮膚貼片市場佔有率（%）

近年來，由於各種慢性疾病的全球盛行率不斷增加，經皮皮膚貼片的全球市場受到關注。經皮皮膚貼片提供了便捷的藥物傳遞方式，與傳統的藥物傳遞方法相比具有多種優點。這些貼片以預定的速率和預定的時間將藥物通過皮膚輸送到血液中。可最大程度地減少口服給藥的胃刺激並允許藥物長時間釋放。此外，經皮皮膚貼片提供非侵入性、無痛的藥物輸送，提高患者對治療的遵從性。老年人口的增加、自我給藥需求的增加以及對方便的藥物輸送系統的需求不斷成長是預計未來幾年推動經皮皮膚貼片需求的一些主要因素。

市場動態：

心血管疾病、糖尿病、慢性疼痛、癌症和神經病變等慢性疾病的盛行率不斷上升，是推動全球採用經皮皮膚貼片的主要因素。此外，老年人口的增加也推動了市場的成長，老年人口更容易罹患慢性病。由於非侵入性、無針給藥系統方便易用，患者和看護者越來越偏好這種系統，這進一步推動了對經皮皮膚貼片的需求。另一方面，與基於經皮皮膚貼片的藥物輸送系統相關的高開發成本以及與臨床試驗相關的監管挑戰是預計在預測期內在一定程度上抑制市場成長的一些因素。然而，配方技術的進步提高更廣泛的藥物傳輸速度。預計這將為市場參與者提供利潤豐厚的成長機會。

本研究的主要特點

本報告對全球經皮皮膚貼片市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據以下參數對全球經皮皮膚貼片市場的主要企業進行了介紹 - 公司亮點、產品系列、主要亮點、財務表現和策略。
主要公司包括Novartis AG、Purdue Pharma LP、Viatris, Inc.、Teikoku Pharma USA, Inc.、Johnson &Johnson Services, Inc.、Teva Pharmaceutical Industries Ltd.、LUYE PHARMA AG、Samyang Holdings Corporation、Vektor Pharma、Hisamitsu Pharmaceutical Co. 。
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球經皮皮膚貼片市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球經皮皮膚貼片市場的各種策略矩陣來促進他們的決策。

公司簡介
- Novartis AG
- Purdue Pharma LP
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson &Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB SA
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

第10章分析師觀點

Wheel of Fortune
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5085

The global transdermal skin patches market is estimated to be valued at USD 8.79 Bn in 2024 and is expected to reach USD 12.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 8.79 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	5.50%	2031 Value Projection:	US$ 12.82 Bn

Figure. Transdermal Skin Patches Market Share (%), By Region, 2024

The global transdermal skin patches market has been gaining traction over the past few years owing to the growing prevalence of various chronic diseases globally. Transdermal skin patches provide a convenient mode of delivery of drugs and offer several advantages over conventional drug delivery methods. These patches administer medication through the skin and into the bloodstream at a predetermined rate for an intended duration. They minimize gastric irritation caused by oral administration of drugs and provide controlled release of drug for an extended period of time. Moreover, transdermal skin patches offer non-invasive and painless delivery of drugs, which enhances patient compliance in therapy. Rising geriatric population, increasing demand for self-administration of drugs, and growing need for convenient drug delivery systems are some of the key factors anticipated to fuel the demand for transdermal skin patches in the coming years.

Market Dynamics:

Growing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, chronic pain, cancer, and neurological disorders, is a key factor boosting the adoption of transdermal skin patches globally. Moreover, the rising geriatric population who are more prone to develop chronic conditions is also augmenting the market growth. The growing preference of patients and care-givers for non-invasive and needle-free drug delivery systems owing to convenience and ease-of-use is further propelling the demand for transdermal skin patches. On the other hand, high development costs associated with transdermal patch-based drug delivery systems and regulatory challenges pertaining to clinical trials are some of the factors expected to restrain the market growth to a certain extent over the forecast period. However, ongoing advancements in formulation technologies are aimed at enhancing delivery rates of a wider range of drugs. This is expected to offer lucrative growth opportunities for players in this market.

Key Features of the Study:

This report provides an in-depth analysis of the global transdermal skin patches market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global transdermal skin patches market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Novartis AG, Purdue Pharma L.P., Viatris, Inc., Teikoku Pharma USA, Inc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., LUYE PHARMA AG, Samyang Holdings Corporation, Vektor Pharma, Hisamitsu Pharmaceutical Co.,Inc., UCB S.A., Hikma Pharmaceuticals PLC , Corium, Inc., Nitto Denko Corporation, Gedeon Richter Plc., Agile Therapeutics, Amneal Pharmaceuticals LLC., Cipla, and AdhexPharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global transdermal skin patches market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transdermal skin patches market.

Detailed Segmentation-

By Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
By Application:
- Pain Relief
- Smoking Cessation
- Overactive Bladder
- Hormonal Therapy
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Purdue Pharma L.P.
- Viatris, Inc.
- Teikoku Pharma USA, Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- LUYE PHARMA AG
- Samyang Holdings Corporation
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Transdermal Skin Patches Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Transdermal Skin Patches Market, By Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Single-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multi-layer Drug-in-Adhesive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Matrix
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Transdermal Skin Patches Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pain Relief
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Smoking Cessation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Overactive Bladder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hormonal Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Transdermal Skin Patches Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Transdermal Skin Patches Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Purdue Pharma L.P.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatris, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teikoku Pharma USA, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LUYE PHARMA AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Samyang Holdings Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vektor Pharma
- Hisamitsu Pharmaceutical Co., Inc.
- UCB S.A.
- Hikma Pharmaceuticals PLC
- Corium, Inc.
- Nitto Denko Corporation
- Gedeon Richter Plc.
- Agile Therapeutics
- Amneal Pharmaceuticals LLC.
- Cipla
- AdhexPharma